06/05/2026
The U.S. Food and Drug Administration has launched a safety study of mifepristone, the abortion pill used in medication abortions. According to reports, the study will review hundreds of thousands of cases and examine safety outcomes associated with the drug.
Human Life Alliance welcomes this review.
"How many more mothers have to die from complications of mail-order abortion drugs because they had no medical oversight?
We welcome the review, and we encourage the Supreme Court to defend state laws established to defend the lives of unborn. These mail-order abortion drugs violate the Comstock Act and sound medical judgement. They must be found unsafe and banned."
-Andy Aplikowski, Executive Director of Human Life Alliance